Viewing StudyNCT00370383



Ignite Creation Date: 2024-05-05 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00370383
Status: COMPLETED
Last Update Posted: 2012-08-07
First Post: 2006-08-30

Brief Title: A Study Comparing Sequential Satraplatin Erlotinib to Erlotinib in Unresectable Stage 34 Non-small-cell Lung Cancer NSCLC
Sponsor:
Organization: Agennix